type of phentermine
Prior to this initiative, the Oregon Tobacco Quitline provided one 30 minute telephone type of phentermine session with no NRT and promoted the service through paid advertising. Analysis of the one year results showed that the free NRT initiative was extremely successful even though its total costs were higher than the costs of the pre initiative program ($2.25 million versus $1.97 million) because: the number of callers nearly doubled (from 6,428 to 13,646). quit rate nearly doubled (from 8.2 percent to 15.7 percent). number of quitters quadrupled (from 527 to 2142). cost per quit fell more than $2,600 (from $3,778 to $1,050). “Cigarette smoking is the number one preventable cause of death and disease in this country, with more than 430,000 Americans dying from cigarette smoking every year. This study shows that offering free nicotine replacement therapy as part of Quitline type of phentermine can dramatically increase the number of smokers who quit and reduce the average cost per quit, ” said Jeffrey Fellows, PhD, lead author and an investigator at Kaiser Permanente’s CHR. The second study looked at 4,600 smokers and is the largest randomized trial ever conducted on the effectiveness and cost effectiveness of alternative Quitline services and polices. Smokers in the study were randomly assigned to one of six levels of services when they called the Oregon Tobacco Quitline: brief type of phentermine (one 15 minute call) with or without NRT, moderate type of phentermine (one 30 minute call and one follow up call) with or without NRT, or intensive type of phentermine (one 30 minute call and four follow up calls) with or without NRT. More than 21 percent of the smokers quit after receiving intensive type of phentermine plus NRT, compared to 11.7 percent of the smokers who quit after brief type of phentermine with no NRT. Successful quitting was defined as abstinence from all forms of tobacco for 30 plus days at the 12 month follow up interview. The study also found that satisfaction with Quitline services also increased with the more intense levels of service, rising to 92.5 percent satisfaction from 53.9 percent from those who just received brief type of phentermine. As expected, costs per participant were higher for increased levels of service, ranging from $67 for brief type of phentermine with no NRT to $268 for intensive type of phentermine plus NRT. The added costs of increased type of phentermine and NRT were offset by their increased effectiveness, and all levels of service were highly cost effective enhancements to brief type of phentermine with no NRT. “Policymakers for state Quitlines might choose to offer only brief type of phentermine with no NRT because the cost per caller is lower,” said Jack Hollis, PhD, lead author of the study and a senior investigator at Kaiser Permanente’s CHR. “However, our results suggest that higher quit rates, greater client satisfaction, and the potential to attract more smokers to Quitlines more than offset the modest additional costs. Heavily addicted smokers, who have the highest health care costs over time, may benefit even more from intensive type of phentermine and medication.” "The state of Oregon has been a national leader in supporting research efforts to determine how best to use its Quitline to serve tobacco users. The unique partnership between the Oregon Health Department, Kaiser Permanente's Center for Health Research, and the Quitline service provider (Free & Clear) has resulted in major breakthroughs in our understanding of how nicotine patches and phone type of phentermine can be provided to increase use of services and help people quit,” said Tim McAfee, MD, MPH, a co investigator on both studies. ### Every state in the United States has a Quitline that provides telephone based smoking cessation services, ranging from a single type of phentermine call to multiple type of phentermine calls plus free nicotine replacement therapy. The national Quitline number is 1 800 QUIT NOW. Quitline services analyzed in both studies were provided by Free & Clear, Inc., through contracts with the state of Oregon. Co authors on the articles included Tim McAfee, Susan Zbikowski, PhD, Terry Bush, PhD from Free & Clear, and Michael Stark, Oregon Department of Human Services. The study of the Oregon Tobacco Quitline’s free NRT initiative was supported by the Oregon Tobacco Prevention and Evaluation Program, Oregon Department of Human Services, and the U.S. Centers for Disease Control and Prevention. The study of the Oregon Tobacco Quitline randomized trial was also supported by the Oregon Tobacco Prevention and Evaluation Program, and by a grant from the National Cancer Institute. GlaxoSmithKline supplied the nicotine patches used in the study. About Kaiser Permanente Kaiser Permanente is America’s leading integrated health plan. Founded in 1945, it is a not for profit; group practice prepayment program headquartered in Oakland, Calif. Kaiser Permanente serves the health care needs of more than 8.7 million members in nine states and the District of Columbia. Today it encompasses the not for profit Kaiser Foundation Health Plan, Inc., Kaiser Foundation Hospitals and their subsidiaries, and the for profit Permanente Medical Groups. Nationwide, Kaiser Permanente includes approximately 156,000 technical, administrative and clerical employees and caregivers, and more than 13, 000 physicians representing all specialties. For more Kaiser Permanent , visit the KP News Center at: About Kaiser Permanente’s Center for Health Research Kaiser Permanente's Center for Health Research, founded in 1964, is a nonprofit research institution dedicated to advancing knowledge to improve health. It has facilities in Portland, Ore., and Honolulu. Find out more through the center's website: ... type of phentermine